Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium phosphates injection is a sterile, non-pyrogenic, concentrated solution containing a mixture of monobasic potassium phosphate and dibasic potassium phosphate in water for injection. It is indicated as a source of phosphorus to correct hypophosphatemia in adult and pediatric patients when oral or enteral replacement is not possible, insufficient, or contraindicated. It is also used as an additive in parenteral nutrition formulas to provide phosphorus and potassium. The injection must be diluted before intravenous administration, and patients should be monitored for serum phosphorus, potassium, calcium, and magnesium levels to avoid complications such as hyperkalemia or hyperphosphatemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium phosphates injection.